American Cancer Society

DUPIXENT has shown positive pivotal results for COPD, confirming the key role of IL-4 and IL-13 in type 2 inflammatory diseases. DUPIXENT has the potential to be the first biologic with unprecedented and paradigm-shifting clinical results to treat COPD, having demonstrated a statistically significant reduc...

It is needless to mention that the tug-of-war between cancer and researchers has been growing stronger and stronger. On one side, cancer has positioned itself as a leading cause of death and on the other side, scientists have been working diligently to find out more effective cancer treatments. According to the Amer...

Cancer treatment methodologies are always evolving, and there cannot be any denying to the fact. In this uninterrupted pursuit, old formulas are sometimes used in new ways, arousing hopes for patients as well as commercial treatment providers. A case in point is the usage of light, which has long been used to see ca...

In the grueling quest for discovering more effective cancer treatment therapies, researchers every now and then come up with interesting breakthroughs, which flash rays of hope not only to the patients, but also for the drug manufacturers to capitalize upon the discoveries. A research team, at the Houston University...